Trial Profile
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Alosetron (GR68755) in Female Subjects With Irritable Bowel Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2015
Price :
$35
*
At a glance
- Drugs Alosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.